{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:23:19Z","timestamp":1747207399748,"version":"3.40.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2021,7,26]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chronic Myeloid Leukemia (CML) is characterized by a reciprocal translocation t(9;22)\nand forms BCR\/ABL1 fusion gene called the Philadelphia chromosome. The therapeutic targets for CML patients\nmediated with BCR\/ABL1 oncogenic are tyrosine kinase inhibitors such as imatinib, dasatinib, and nilotinib. The\nlatter two of which have been approved for the treatment of imatinib-resistant or intolerance CML patients.\nMitotic Catastrophe (MC) is one of the non-apoptotic mechanisms initiated in types of cancer cells in response to\nanti-cancer therapies. Pharmacological inhibitors of G2 checkpoint members or genetic suppression of PLK1,\nPLK2, ATR, ATM, CHK1, and CHK2 can trigger DNA-damage-stimulated mitotic catastrophe. PLK1 and\nAURKA\/B are anomalously expressed in CML cells, where phosphorylation and activation of PLK1 occur by\nAURKB at centromeres and kinetochores.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this study is to investigate the effect of dasatinib on the expression of genes in MC and\napoptosis pathways in K562 cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Total RNA was isolated from K-562 cells treated with the IC<jats:sub>50<\/jats:sub> value of dasatinib and untreated cells as\na control group. The expression of MC and apoptosis-related genes, was analyzed by the qRT-PCR system.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The array-data demonstrated that dasatinib-treated K562 cells significantly caused the decrease of\nseveral genes (AURKA, AURKB, PLK, CHEK1, MYC, XPC, BCL2, and XRCC2).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The evidence supplies a basis to support clinical researches for the suppression of oncogenes such\nas PLKs with AURKs in the treatment of types of cancer, especially chronic myeloid leukemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520620666201106085929","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T14:45:21Z","timestamp":1604673921000},"page":"1724-1731","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Dasatinib on Genes Related to Mitotic Catastrophe Pathway in Chronic Myeloid Leukemia Cells"],"prefix":"10.2174","volume":"21","author":[{"given":"Sezgi","family":"Kipcak","sequence":"first","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buket","family":"Ozel","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigir B.","family":"Avci","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-7150","authenticated-orcid":true,"given":"Leila S.","family":"Takanlou","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam S.","family":"Takanlou","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumhur","family":"Gunduz","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur S.","family":"Gunel","sequence":"additional","affiliation":[{"name":"Deparment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/187656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187656\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/187656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T03:56:08Z","timestamp":1627617368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187656\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,7,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520620666201106085929","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2021,7,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}